AbbVie

Yahoo Finance • 5 hours ago

3 High-Yielding Dividend Stocks That Retirees Can Buy and Forget About

"Buy and hold" is a simple strategy for investors, but it can be a hard one to stick to in actual practice. That's because many people want to pick stocks and trade them, and feel like they need to actively intervene to generate significan... Full story

Yahoo Finance • 2 days ago

High Growth Tech Stocks To Watch In The US April 2025

Over the last 7 days, the United States market has dropped 3.4%, yet it remains up by 6.1% over the past year, with earnings anticipated to grow by 14% annually in the coming years. In this context, identifying high growth tech stocks invo... Full story

Yahoo Finance • 3 days ago

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.

Building a retirement portfolio of $1 million or more is within reach for many Americans. The primary things you'll need are time and money to invest. Do you want $1 million in retirement? There's no guarantee that you'll be able to achie... Full story

Yahoo Finance • 4 days ago

AbbVie Inc. (ABBV): Among the Best Dividend Aristocrat Stocks with Over 3% Yield

We recently published a list of the 15 Best Dividend Aristocrat Stocks with Over 3% Yield. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend aristocrats with a high yield. Div... Full story

Yahoo Finance • 8 days ago

2 Dividend Stocks Defying the Market Dip to Buy for a Lifetime of Passive Income

Equities haven't performed well this year due to a combination of factors. Macroeconomic tensions are at the top of that list. Still, some companies are doing just fine amid the volatility, including AbbVie(NYSE: ABBV) and Abbott Laborator... Full story

Yahoo Finance • 18 days ago

1 No-Brainer High-Yield Dividend ETF to Buy During the Stock Market Correction

Stock market sell-offs are often great opportunities to buy dividend stocks. That's because dividend yields move in the opposite direction of stock prices. So, with the stock market recently correcting (defined as a decline of 10% or more... Full story

Yahoo Finance • 18 days ago

AbbVie (NYSE:ABBV) Reports ELAHERE Success in Phase 3 Trials for Platinum-Resistant Ovarian Cancer

AbbVie has recently seen promising developments with the release of favorable final results from the MIRASOL trial of ELAHERE, demonstrating significant improvements for women with platinum-resistant ovarian cancer. Over the last quarter,... Full story

Yahoo Finance • 24 days ago

This Top Dividend Stock Just Entered The Weight Loss Market: Is It a Buy?

It's not too often that pharmaceutical drugs become household names, but that's happening with medicines in the weight loss market. Brands such as Wegovy and Zepbound -- the leading anti-obesity therapies -- are now well known and are gene... Full story

Yahoo Finance • 30 days ago

SKYRIZI® (risankizumab) Now Available for Moderately to Severely Active Ulcerative Colitis, Expanding AbbVie's Portfolio Across Inflammatory Bowel Disease

SKYRIZI is the first IL-23 specific inhibitor approved for both moderate to severe ulcerative colitis and moderate to severe Crohn's disease.1 MONTREAL, March 4, 2025 /CNW/ - AbbVie (NYSE: ABBV) announced today that SKYRIZI® (risankizumab... Full story

Yahoo Finance • 30 days ago

AbbVie to Present at the Leerink Partners Global Healthcare Conference

NORTH CHICAGO, Ill., March 4, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate at the Leerink Partners Global Healthcare Conference on Tuesday, March 11, 2025. Management will participate in a fireside chat at 7:40 a.m. Central ti... Full story

Yahoo Finance • 2 months ago

John Rogers' Strategic Moves: A Closer Look at Royal Caribbean Group's Impact

Exploring the Latest 13F Filing and Key Investment Adjustments John Rogers (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2024, providing insights into his investment moves during this period. John Rogers... Full story

Yahoo Finance • 2 months ago

AbbVie Declares Quarterly Dividend

NORTH CHICAGO, Ill., Feb. 13, 2025 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share. The cash dividend is payable May 15, 2025, to stockholders of record at the... Full story

Yahoo Finance • 2 months ago

AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies

Collaboration will combine AbbVie’s oncology expertise and Xilio’s proprietary tumor-activation technology to develop novel immunotherapies, including masked T-cell engagersXilio to host investor conference call and webcast today at 8:30 a... Full story

Yahoo Finance • 2 months ago

3 Fabulous Dividend Stocks to Buy in February

February is the shortest month, but that doesn't mean income investors don't have much time to find great stocks. Three Motley Fool contributors believe they have identified fabulous dividend stocks to buy this month. Here's why they like... Full story

Yahoo Finance • 2 months ago

68-Year-Old Earning $4,300/Month in Dividends Shares His Top 7 Stock Picks — 'Dividends Have Been Consistent, Stable'

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. U.S. markets were seeing volatility as technology earnings began to worry investors due to soft forecasts and mounting AI-related expense... Full story

Yahoo Finance • 2 months ago

3 US Stocks Estimated To Be Undervalued For Savvy Investors

As the U.S. market hovers near record highs, investors are closely monitoring the upcoming January jobs report for insights into economic health and interest rate trends. In this environment, identifying stocks that may be undervalued can... Full story

Yahoo Finance • 2 months ago

3 Stocks That Investors Might Be Undervaluing By Up To 43.3%

In the current global market landscape, investors are navigating a complex environment marked by fluctuating interest rates, geopolitical tensions, and volatile corporate earnings. With U.S. stocks experiencing a mixed performance and Euro... Full story

Yahoo Finance • 2 months ago

If You Invested $10,000 In AbbVie Stock 10 Years Ago, How Much Would You Have Now?

If You Invested $10,000 In AbbVie Stock 10 Years Ago, How Much Would You Have Now? Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. AbbVie Inc. (NYSE:ABBV) discovers, develops, manufact... Full story

Yahoo Finance • 2 months ago

Is AbbVie Inc. (ABBV) The Best Bear Market Stock To Invest In Now?

We recently published a list of 11 Best Bear Market Stocks To Invest In Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best bear market stocks to invest in now. As of January 2025,... Full story

Yahoo Finance • 2 months ago

Got $500? 2 Pharmaceutical Stocks to Buy and Hold Forever

You've probably heard this before: Pharmaceutical stocks can bring an element of safety to your portfolio. Why is this the case? These companies make drugs doctors and patients rely on -- and that means no matter what the economy is doing,... Full story